Wells Fargo & Company Invitae Corp Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.42 - $0.72 $4,947 - $8,480	-11,779 Reduced 9.07%	118,098 $74,000
Q3 2023 Nov 13, 2023	SELL	$0.6 - $1.53 $363,620 - $927,232	-606,034 Reduced 82.35%	129,877 $77,000
Q2 2023 Aug 15, 2023	BUY	$1.05 - $1.63 $114,259 - $177,374	108,819 Added 17.35%	735,911 $831,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.73 $638,902 - $1.45 Million	532,419 Added 562.38%	627,092 $846,000
Q4 2022 Feb 13, 2023	BUY	$1.71 - $3.61 $28,560 - $60,294	16,702 Added 21.42%	94,673 $176,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $4,816 - $21,877	-2,535 Reduced 3.15%	77,971 $192,000
Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $145,981 - $617,509	-68,536 Reduced 45.98%	80,506 $197,000
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $476,055 - $1.18 Million	-75,805 Reduced 33.71%	149,042 $1.19 Million
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $273,522 - $533,462	-18,607 Reduced 7.64%	224,847 $3.43 Million
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $721,545 - $997,281	-29,681 Reduced 10.87%	243,454 $6.92 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $9.3 Million - $14.4 Million	-356,306 Reduced 56.61%	273,135 $9.21 Million
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $5.68 Million - $9.78 Million	-171,862 Reduced 21.45%	629,441 $24.1 Million
Q4 2020 Feb 09, 2021	SELL	$39.09 - $57.4 $11.6 Million - $17 Million	-296,118 Reduced 26.98%	801,303 $33.5 Million
Q3 2020 Nov 05, 2020	BUY	$28.43 - $44.67 $10.3 Million - $16.1 Million	361,167 Added 49.05%	1,097,421 $47.6 Million
Q2 2020 Aug 13, 2020	SELL	$11.71 - $30.29 $269,060 - $695,973	-22,977 Reduced 3.03%	736,254 $22.3 Million
Q1 2020 May 14, 2020	BUY	$7.64 - $27.5 $5.8 Million - $20.9 Million	759,231 New	759,231 $10.4 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account